Tandem Diabetes Care Inc
NASDAQ:TNDM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
US |
|
BASF India Ltd
NSE:BASF
|
IN |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
SWB:MUV2
|
DE |
|
B
|
BKW AG
SWB:B9W
|
CH |
|
CaixaBank SA
OTC:CIXPF
|
ES |
|
C
|
Cardinal Health Inc
F:CLH
|
US |
|
H
|
Hornbach Baumarkt AG
XHAM:HBM
|
DE |
|
E
|
Experian PLC
OTC:EXPGF
|
IE |
|
S
|
Sempra Energy
F:SE4
|
US |
|
Prudential PLC
LSE:PRU
|
HK |
|
Dexus
F:0DPS
|
AU |
|
W
|
Whitehaven Coal Ltd
SWB:WC2
|
AU |
|
Shiseido Co Ltd
TSE:4911
|
JP |
|
E
|
Element Solutions Inc
F:PLQ
|
US |
|
F
|
Federal Home Loan Mortgage Corp
XHAM:FHL
|
US |
|
Daiichi Life Group Inc
OTC:DCNSF
|
JP |
Wall St Price Targets
TNDM Price Targets Summary
Tandem Diabetes Care Inc
According to Wall Street analysts, the average 1-year price target for
TNDM is 27.54 USD with a low forecast of 18.18 USD and a high forecast of 52.5 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TNDM's stock price target?
Price Target
27.54
USD
According to Wall Street analysts, the average 1-year price target for
TNDM is 27.54 USD with a low forecast of 18.18 USD and a high forecast of 52.5 USD.
What is the Revenue forecast for Tandem Diabetes Care Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 59%. The projected CAGR for the next 8 years is 8%.
What is the Gross Profit forecast for Tandem Diabetes Care Inc?
Projected CAGR
9%
The compound annual growth rate for Gross Profit over the next 8 years is 9%.